US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist
  • 20.540
  • +0.280+1.38%
Close Nov 22 16:00 ET
  • 20.540
  • 0.0000.00%
Post 16:00 ET
1.42BMarket Cap-6262P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
86.52%26.98M
67.38%5.33M
76.05%5.35M
160.32%11.4M
26.84%4.9M
23.65%14.46M
-15.54%3.19M
Operating revenue
-50.00%2.68M
-17.86%9.36M
298.90%19.53M
86.52%26.98M
67.38%5.33M
76.05%5.35M
160.32%11.4M
26.84%4.9M
23.65%14.46M
-15.54%3.19M
Cost of revenue
Gross profit
Operating expense
19.42%66.2M
2.21%56.11M
10.97%51.32M
65.69%216.33M
68.62%59.75M
67.99%55.44M
77.10%54.9M
48.56%46.25M
68.87%130.56M
63.46%35.43M
Selling and administrative expenses
15.23%17.94M
5.75%16.05M
17.23%16.45M
22.23%59.83M
40.48%15.05M
51.92%15.57M
36.20%15.18M
-16.69%14.04M
50.92%48.95M
22.85%10.72M
-General and administrative expense
15.23%17.94M
5.75%16.05M
17.23%16.45M
22.23%59.83M
40.48%15.05M
51.92%15.57M
36.20%15.18M
-16.69%14.04M
50.92%48.95M
22.85%10.72M
Research and development costs
21.06%48.27M
0.85%40.06M
8.24%34.86M
91.76%156.5M
80.82%44.7M
75.23%39.87M
100.06%39.72M
125.50%32.21M
81.84%81.61M
90.79%24.72M
Operating profit
-26.84%-63.53M
-7.46%-46.75M
23.13%-31.79M
-63.10%-189.35M
-68.74%-54.42M
-67.17%-50.08M
-63.41%-43.5M
-51.63%-41.35M
-76.93%-116.1M
-80.09%-32.25M
Net non-operating interest income expense
232.70%10.55M
77,322.22%6.95M
126.45%4.8M
345.23%10.74M
200.94%5.46M
170.10%3.17M
-136.00%-9K
453.50%2.12M
184.22%2.41M
338.24%1.81M
Non-operating interest income
165.57%10.58M
857.39%7.77M
92.01%5.62M
143.26%14M
137.82%6.28M
100.15%3.99M
-10.57%812K
1,243.58%2.93M
4,696.67%5.76M
4,372.88%2.64M
Non-operating interest expense
-95.95%33K
0.37%824K
1.61%821K
-2.42%3.26M
-0.73%820K
-0.37%814K
-7.02%821K
-1.22%808K
12.06%3.34M
0.73%826K
Other net income (expense)
-78.29%-1.27M
-74.10%101K
115.67%71K
-7.03%-594K
381.58%183K
-457.00%-714K
157.35%390K
-300.88%-453K
-555K
38K
Gain on sale of security
55.32%-319K
-74.10%101K
115.67%71K
-7.03%-594K
381.58%183K
-457.00%-714K
157.35%390K
-300.88%-453K
---555K
--38K
Special income (charges)
---954K
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
--954K
----
----
----
----
----
----
----
----
----
Income before tax
-13.91%-54.25M
7.94%-39.7M
32.18%-26.91M
-56.87%-179.21M
-60.47%-48.78M
-66.61%-47.63M
-58.09%-43.12M
-41.81%-39.68M
-66.82%-114.24M
-61.82%-30.4M
Income tax
-251.76%-3.45M
122.24%115K
43.37%-350K
195.60%1.46M
176.19%320K
1,054.62%2.27M
-15.66%-517K
-47.49%-618K
8.36%-1.52M
43.85%-420K
Net income
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
Net income continuous Operations
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
Minority interest income
Net income attributable to the parent company
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.81%-50.8M
6.55%-39.81M
32.00%-26.56M
-60.28%-180.66M
-63.78%-49.1M
-76.03%-49.9M
-58.80%-42.6M
-41.72%-39.06M
-68.69%-112.72M
-66.20%-29.98M
Basic earnings per share
41.27%-0.74
45.39%-0.77
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.3
-42.32%-3.8
-60.32%-1.01
Diluted earnings per share
41.27%-0.74
45.39%-0.77
52.31%-0.62
-33.68%-5.08
-14.85%-1.16
-31.25%-1.26
-56.67%-1.41
-39.78%-1.3
-42.32%-3.8
-60.32%-1.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -50.00%2.68M-17.86%9.36M298.90%19.53M86.52%26.98M67.38%5.33M76.05%5.35M160.32%11.4M26.84%4.9M23.65%14.46M-15.54%3.19M
Operating revenue -50.00%2.68M-17.86%9.36M298.90%19.53M86.52%26.98M67.38%5.33M76.05%5.35M160.32%11.4M26.84%4.9M23.65%14.46M-15.54%3.19M
Cost of revenue
Gross profit
Operating expense 19.42%66.2M2.21%56.11M10.97%51.32M65.69%216.33M68.62%59.75M67.99%55.44M77.10%54.9M48.56%46.25M68.87%130.56M63.46%35.43M
Selling and administrative expenses 15.23%17.94M5.75%16.05M17.23%16.45M22.23%59.83M40.48%15.05M51.92%15.57M36.20%15.18M-16.69%14.04M50.92%48.95M22.85%10.72M
-General and administrative expense 15.23%17.94M5.75%16.05M17.23%16.45M22.23%59.83M40.48%15.05M51.92%15.57M36.20%15.18M-16.69%14.04M50.92%48.95M22.85%10.72M
Research and development costs 21.06%48.27M0.85%40.06M8.24%34.86M91.76%156.5M80.82%44.7M75.23%39.87M100.06%39.72M125.50%32.21M81.84%81.61M90.79%24.72M
Operating profit -26.84%-63.53M-7.46%-46.75M23.13%-31.79M-63.10%-189.35M-68.74%-54.42M-67.17%-50.08M-63.41%-43.5M-51.63%-41.35M-76.93%-116.1M-80.09%-32.25M
Net non-operating interest income expense 232.70%10.55M77,322.22%6.95M126.45%4.8M345.23%10.74M200.94%5.46M170.10%3.17M-136.00%-9K453.50%2.12M184.22%2.41M338.24%1.81M
Non-operating interest income 165.57%10.58M857.39%7.77M92.01%5.62M143.26%14M137.82%6.28M100.15%3.99M-10.57%812K1,243.58%2.93M4,696.67%5.76M4,372.88%2.64M
Non-operating interest expense -95.95%33K0.37%824K1.61%821K-2.42%3.26M-0.73%820K-0.37%814K-7.02%821K-1.22%808K12.06%3.34M0.73%826K
Other net income (expense) -78.29%-1.27M-74.10%101K115.67%71K-7.03%-594K381.58%183K-457.00%-714K157.35%390K-300.88%-453K-555K38K
Gain on sale of security 55.32%-319K-74.10%101K115.67%71K-7.03%-594K381.58%183K-457.00%-714K157.35%390K-300.88%-453K---555K--38K
Special income (charges) ---954K------------------0----------------
-Less:Other special charges --954K------------------------------------
Income before tax -13.91%-54.25M7.94%-39.7M32.18%-26.91M-56.87%-179.21M-60.47%-48.78M-66.61%-47.63M-58.09%-43.12M-41.81%-39.68M-66.82%-114.24M-61.82%-30.4M
Income tax -251.76%-3.45M122.24%115K43.37%-350K195.60%1.46M176.19%320K1,054.62%2.27M-15.66%-517K-47.49%-618K8.36%-1.52M43.85%-420K
Net income -1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M
Net income continuous Operations -1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M
Minority interest income
Net income attributable to the parent company -1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.81%-50.8M6.55%-39.81M32.00%-26.56M-60.28%-180.66M-63.78%-49.1M-76.03%-49.9M-58.80%-42.6M-41.72%-39.06M-68.69%-112.72M-66.20%-29.98M
Basic earnings per share 41.27%-0.7445.39%-0.7752.31%-0.62-33.68%-5.08-14.85%-1.16-31.25%-1.26-56.67%-1.41-39.78%-1.3-42.32%-3.8-60.32%-1.01
Diluted earnings per share 41.27%-0.7445.39%-0.7752.31%-0.62-33.68%-5.08-14.85%-1.16-31.25%-1.26-56.67%-1.41-39.78%-1.3-42.32%-3.8-60.32%-1.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data